At Close: 4:00 PM
After Market: 10:43 PM
ARDX Stock Price Today
Ardelyx, Inc. (ARDX) stock rallied over 5.12% intraday to trade at $3.08 a share on NASDAQ. The stock opened with a gain of 1.71% at $2.98 and touched an intraday high of $3.29, rising 5.12% against the last close of $2.93. The Ardelyx, Inc. in stock market went to a low of $2.98 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue$5.2 Million
5Y Sales Change-
Fiscal Year EndsDec. 2021
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult patients with chronic kidney disease (CKD)on dialysis, or hyperphosphatemia. It is also developing RDX013, a potassium secretagogue, for the treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease; and RDX020, an early-stage program in metabolic acidosis, a serious electrolyte disorder in patients with CKD. The company has agreements with Kyowa Kirin in Japan, Fosun Pharmaceutical Industrial Development Co. Ltd. in China, and Knight Therapeutics, Inc. in Canada for the development and commercialization of tenapanor in their respective territories. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Frequently Asked Questions
What is the current Ardelyx, Inc. (ARDX) stock price?
Ardelyx, Inc. (NASDAQ: ARDX) stock price is $3.08 in the last trading session. During the trading session, ARDX stock reached the peak price of $3.29 while $2.98 was the lowest point it dropped to. The percentage change in ARDX stock occurred in the recent session was 5.12% while the dollar amount for the price change in ARDX stock was $0.15.
ARDX's industry and sector of operation?
The NASDAQ listed ARDX is part of Biotechnology industry that operates in the broader Health Care sector. Ardelyx, Inc. , a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally.
Who are the executives of ARDX?
Mr. Michael G. Raab
Pres, CEO & Director
Mr. Justin A. Renz CPA, M.S.T., MBA, MST
CFO & Treasurer
Ms. Elizabeth A. Grammer
Chief Legal & Admin. Officer and Sec.
Mr. David P. Rosenbaum
Chief Devel. Officer
How ARDX did perform over past 52-week?
ARDX's closing price is 5.29% higher than its 52-week low of $0.49 where as its distance from 52-week high of $3.43 is -0.10%.
How many employees does ARDX have?
Number of ARDX employees currently stands at 86. ARDX operates from 400 Fifth Avenue, Suite 210, Waltham, MA 02451, United States.
Link for ARDX official website?
Official Website of ARDX is: https://www.ardelyx.com
How do I contact ARDX?
How many shares of ARDX are traded daily?
ARDX stock volume for the day was 8,110,157 shares. The average number of ARDX shares traded daily for last 3 months was 11.26 Million.
What is the market cap of ARDX currently?
The market value of ARDX currently stands at $593.64 Million with its latest stock price at $3.08 and 187.46 Million of its shares outstanding.